Workflow
恒光股份: 西部证券股份有限公司关于湖南恒光科技股份有限公司部分募投项目延期的核查意见

Core Viewpoint - The company, Hunan Hengguang Technology Co., Ltd., has decided to postpone certain fundraising projects due to actual progress and market conditions, ensuring that the adjustments do not affect the overall investment direction or shareholder interests [7][12]. Fundraising Overview - The company raised a total of RMB 605.41 million through its initial public offering, with a net amount of RMB 540.81 million after deducting related issuance costs [1][2]. Fund Usage Status - As of May 31, 2025, the company has invested RMB 343.30 million, which is 60.57% of the total planned investment of RMB 566.81 million for the first phase of the fine chemical new materials production base [4]. Project Postponement Details - The company has postponed the completion date of the "5.5 million tons fine chemical new materials production line construction project" from June 30, 2025, to December 31, 2026, due to technical optimizations and market uncertainties [9][11]. Reasons for Postponement - The postponement is attributed to the need for technical adjustments in the "5,000 tons 2-ethyl anthraquinone production line" and the decision to delay investment in the "50,000 tons sodium chlorite production line" to protect shareholder interests amid a complex market environment [9][10]. Impact of Postponement - The postponement will not change the project content, implementation subject, or total investment amount, and is expected to have no adverse effects on the company's current operations [10][12]. Approval Process - The postponement was approved through necessary procedures by the independent directors, board of directors, and supervisory board, confirming compliance with relevant regulations and ensuring no harm to shareholder interests [10][11][12].